Accès ouvert
2026
article
OpenAlex
Daniele Caracciolo, Maria Rita Lombardo, Gianluca Reitano, Cristina Napoli et autres
Summary Relapsed/refractory follicular lymphoma (R/R FL) remains a clinically challenging condition, with progressively declining benefit across consecutive lines of therapy. While anti‐Cluster of Differentiation 20 (CD20) antibodies remain the therapeutic backbone, the optimal targeted or immune‐based partner remains undefined. A systematic review …
it
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Matteo Lulli, Andrea Trabocchi, Giandomenico Roviello, Martina Catalano et autres
Ovarian cancer is the deadliest gynaecologic malignancies worldwide. Platinum based chemotherapy is the mainstay treatment for ovarian cancer; however, frequent recurrence and chemoresistance onset in patients with advanced diseases remain a therapeutic challenge. Although mechanisms underlying the development of chemoresistance are still …
it
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Matteo Lulli, Giandomenico Roviello, Martina Catalano, Astrid Parenti et autres
Abstract Purpose Ovarian cancer is the deadliest gynaecologic malignancies worldwide. Platinum based chemotherapy is the mainstay treatment for ovarian cancer; however, frequent recurrence and chemoresistance onset in patients with advanced diseases remain a therapeutic challenge. Although mechanisms underlying the development of chemoresistance …
it
(code pays fourni par la source)
Accès ouvert
2023
review
OpenAlex
Nicoletta Staropoli, Domenico Ciliberto, Francesco Luciano, Cristina Napoli et autres
BACKGROUND: Carboplatin is still the cornerstone of the first-line treatment in advanced Epithelial Ovarian Cancer (aEOC) management and the clinical response to platinum-derived agents remains the major predictor of long-term outcomes. PATIENT AND METHODS: We aimed to identify the best treatment of …
it, us
(code pays fourni par la source)
Accès ouvert
2023
review
OpenAlex
Domenico Ciliberto, Giulio Caridà, Nicoletta Staropoli, Caterina Romeo et autres
The rapid development of novel therapeutic options for advanced hepatocellular carcinoma (aHCC) has generated some uncertainty about the rational choice of the systemic upfront treatment. So far, a variety of therapeutic strategies have been investigated, including the combination of immunecheckpoint inhibitors and …
it, us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Matteo Lulli, Cristina Napoli, Ida Landini, Enrico Mini et autres
Colorectal cancer is one of the most common causes of cancer-related deaths worldwide. Despite the advances in the knowledge of pathogenetic molecular mechanisms and the implementation of more effective drug treatments in recent years, the overall survival rate of patients remains unsatisfactory. …
it
(code pays fourni par la source)
Accès ouvert
2022
review
OpenAlex
Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, Alessia Cordua et autres
Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence suggests miR-221 as a fine-tuner of chronic liver injury and inflammation-related events. Available information also supports the potential …
it
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Andrea Lapucci, Gabriele Perrone, Antonello Di Paolo, Cristina Napoli et autres
The benefit of adjuvant chemotherapy in the early stages of colorectal cancer (CRC) is still disappointing and the prediction of treatment outcome quite difficult. Recently, through a transcriptomic approach, we evidenced a role ofPNNandKCNQ1OT1gene expression in predicting response to fluoropyrimidine-based adjuvant chemotherapy …
it
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Marco Ciacciarelli, Gianluca Caruso, Marco Rengo, Piero Maceroni et autres
Insulinoma is an insulin-producing pancreatic neuroendocrine tumor that can be malignant in about 10% of cases. Locoregional invasion, lymph node metastases, or remote metastases are the main criteria of malignant insulinoma. Its incidence in patients with pre-existing diabetes mellitus (DM) is exceptionally …
it
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Enrico Mini, Andrea Lapucci, Gabriele Perrone, Romina D’Aurizio et autres
Five-year overall survival of stage III colorectal cancer (CRC) patients treated with standard adjuvant chemotherapy (ACHT) is highly variable. Genomic biomarkers and/or transcriptomic profiles identified lack of adequate validation. Aim of our study was to identify and validate molecular biomarkers predictive of …
it
(code pays fourni par la source)
2019
article
OpenAlex
Cristina Napoli
Accès ouvert
2018
erratum
OpenAlex
Enrico Mini, Ida Landini, Laura Lucarini, Andrea Lapucci et autres
The poly(ADP-ribose) polymerase (PARP) enzymes play a key role in the regulation of cellular processes (e.g., DNA damage repair, genomic stability). It has been shown that PARP inhibitors (PARPIs) are selectively cytotoxic against cells having dysfunctions in genes involved in DNA repair …
it
(code pays fourni par la source)